Inhalation of poorly soluble particles. I. Differences in inflammatory response and clearance during exposure.
Results from animal studies have indicated some uncertainties over the validity of a single general occupational control limit for all types of "particulates (insoluble) not otherwise classified" (PNOC) (ACGIH, 2000). Therefore, to examine the extent to which a given control limit may be valid for nontoxic dusts with different physical characteristics, this study compared the pulmonary effects in rats of inhalation exposure to two poorly soluble dusts of similar density and with relatively low toxicity: titanium dioxide and barium sulfate. The objectives were to compare the dusts in (a) their buildup and clearance in the lungs during inhalation; (b) their transfer to lymph nodes; (c) the changes, with time, in the lavageable cell population; and (d) the pathological change from histology. The exposure aerosol concentrations were selected to achieve similar mass and volume lung burdens for both dusts and to attain "overload" over the common exposure periods of about 4 mo and 7 mo. Despite obtaining similar lung burdens for both dusts, there was significantly more translocation of TiO(2) to the hilar lymph nodes than with BaSO(4). It was also found that clearance of TiO(2) was retarded whereas clearance of BaSO(4) was not. Trends in these data were clarified by the use of a simple model of particle clearance. Retardation of particle clearance and translocation to the lymph nodes are markers of the condition known as "overload" in which the alveolar macrophage-based clearance of particles from the deep lung is impaired. In addition, bronchoalveolar lavage showed that TiO(2) caused significantly more recruitment of inflammatory neutrophils to lungs than BaSO(4). These differences between the dusts were not due to differences in toxicity, solubility, or lung deposition. The explanation that the different responses are due to the different particle size distributions of the two dust types is examined in a companion paper (Tran et al., this issue).
Cullen
R T
RT
Institute of Occupational Medicine, 8 Roxburgh Place, Edinburgh EH8 9SU, United Kingdom. richard.cullen@iomhq.org.uk
Tran
C L
CL
Buchanan
D
D
Davis
J M
JM
Searl
A
A
Jones
A D
AD
Donaldson
K
K
D000280:Administration, Inhalation; D000818:Animals; D001466:Barium Sulfate / Q000493:pharmacokinetics / Q000633:toxicity*; D001822:Body Burden; D004391:Dust / Q000009:adverse effects*; D007249:Inflammation / Q000209:etiology*; D008168:Lung / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D008198:Lymph Nodes / Q000378:metabolism; D008297:Male; D008657:Metabolic Clearance Rate; D009504:Neutrophils / Q000187:drug effects; D051381:Rats; D017208:Rats, Wistar; D012995:Solubility; D014025:Titanium / Q000493:pharmacokinetics / Q000633:toxicity*
D004391:Dust; C009495:titanium dioxide; D001466:Barium Sulfate; D014025:Titanium